ArticleFrontiers in oncology2025
Current and future burden trends of lip and oral cavity cancer based on estimated annual percentage change and the Bayesian age-period-cohort model: a study based on the global burden of disease 2021.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Incidence of Malignant Oral Cavity Tumors in the Republic of Serbia: Trend Analysis (1999-2020) and Projections to 2040.Medicina (Kaunas, Lithuania) · 2026Article
- Diverging trends in motor neuron disease burden in China: an ageing-driven increase despite declining age-standardised rates - a GBD 2021 analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Lip and Oral Cavity Cancer (LOCC), as a common type of malignant cancer, has become an important public health issue. This study aims to analyze and predict the trend of the LOCC burden, providing guidance for reducing the burden of LOCC. Methods: This study was based on the Global Burden of Disease (GBD) database 2021. We assessed the differences in LOCC among different regions and sexes from 1990 to 2021 using Age-Standardized Rates (ASR) and Estimated Annual Percentage Change (EAPC). Additionally, Bayesian Age-Period-Cohort (BAPC) model was employed to predict the Incidence, Prevalence, Death, Disability-Adjusted Life Years (DALYs), Years of Life Lost due to disease (YLLs), and Years Lived with Disability (YLDs) of LOCC globally from 2022 to 2030. Results: From 1990 to 2021, the global ASR of Incidence (ASIR), ASR of Prevalence (ASPR), and ASR of YLDs for LOCC had significantly increased, while the ASR of Death (ASDR), DALYs, and YLLs had decreased. The BAPC model predicted that by 2030, the ASIR and ASPR for males would decrease, while for females, an upward trend would be observed. The middle-aged and elderly population (>50 years) would still be the main patient group (accounting for over 60%). Conclusion: The disease burden of LOCC remains severe at present, but it is expected to show a downward trend by 2030. Therefore, it is still necessary to intensify efforts in the prevention and control of LOCC to achieve the expectation. This study provides theoretical guidance for reducing the burden of LOCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.